Altered expression of neurotrophic factors in patients with major depression
about
Neuroplasticity and the next wave of antidepressant strategiesMinocycline: therapeutic potential in psychiatryFunctional alterations of astrocytes in mental disorders: pharmacological significance as a drug targetAstrocyte pathology in major depressive disorder: insights from human postmortem brain tissueGenomewide association scan of suicidal thoughts and behaviour in major depressionKnockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression.BDNF and Artemin are increased in drug-naïve non-depressed GAD patients: preliminary data.Genetic and epigenetic regulation of the brain-derived neurotrophic factor in the central nervous system.Gene expression studies in major depression.Identification of commonly altered genes between in major depressive disorder and a mouse model of depression.Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system.State-related alterations of gene expression in bipolar disorder: a systematic review.Fluoxetine prevents development of an early stress-related molecular signature in the rat infralimbic medial prefrontal cortex. Implications for depression?The neurobiology of suicide - A Review of post-mortem studies.Depression pathogenesis and treatment: what can we learn from blood mRNA expression?Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis.Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial.Tricyclic antidepressant amitriptyline activates fibroblast growth factor receptor signaling in glial cells: involvement in glial cell line-derived neurotrophic factor production.Developing biomarkers for methamphetamine addiction.Evidence demonstrating role of microRNAs in the etiopathology of major depressionSignificantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review.MicroRNA regulation of central glial cell line-derived neurotrophic factor (GDNF) signalling in depression.Neurotrophins role in depression neurobiology: a review of basic and clinical evidence.Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies.Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder.Effects of electroacupuncture on depression and the production of glial cell line-derived neurotrophic factor compared with fluoxetine: a randomized controlled pilot study.Transcriptomics in Interferon-α-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of Depression.Neurobiology of major depressive disorderSigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor.GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence.Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stressThe hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.Gene expression: biomarker of antidepressant therapy?Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia.The relationship between neurotrophins and bipolar disorder.Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses.Pharmacological modulation of astrocytes and the role of cell type-specific histone modifications for the treatment of mood disordersThe protein and mRNA expression levels of glial cell line-derived neurotrophic factor in post stroke depression and major depressive disorder.Glial cells as key elements in the pathophysiology and treatment of bipolar disorder.Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response.
P2860
Q21129480-04DAE839-33CE-4F85-AA18-9A7CDF445250Q22241418-90F22186-B804-4F15-A57C-7A5609126455Q26798948-35DAF4E8-E1D3-4821-8E87-942BED97599EQ26827833-8EBF309D-F31A-412A-A9AD-BD07686D3431Q28742939-491E9F0D-4E49-4ACD-9C69-67785199165CQ30491061-FFA8DD54-BD9D-493B-8E62-849469FBD5EFQ30835081-FBA59217-3236-446A-88E6-BD84C258257BQ33653087-EE8DA11D-4170-498E-854E-DFD44810DFBDQ33762208-48296E32-616E-45B7-8C8A-4408941B6E79Q33780372-A79FD826-1AE8-46F4-BAF5-49D438ED1AD3Q34311201-FB1E1045-FF6F-42D3-9E3B-3B3B08D8E3B1Q34436227-E1B9CB3C-7BB5-4C2C-8515-C8375057EE0DQ34449524-2381BB25-A177-4ABA-9BFF-65B6C8CDB96AQ34470397-90007531-A927-4AFF-8E04-3C014E398991Q34577617-7C65CEB3-89F4-4209-B923-DE67DE1595DFQ34647315-69423362-89A4-4392-917D-0B018121D4B1Q34942602-CE451762-566E-433E-9A29-FB10D5C565FDQ35065118-B36A5F67-CF19-49F1-A9C2-50672B3C65D7Q35107735-F8BDE005-8F06-47E7-948D-305F49016D9AQ35186527-B8014EC5-A0DF-4435-B7B0-295185CD7701Q35320518-732B5F91-AE74-47F3-96B2-0F9668C4DFCDQ35653848-D41476E8-CCD2-4B60-93A8-436216877761Q35687024-471EFFCA-3C91-4814-97FD-99EF5FF519E5Q36813765-224CA276-F796-4D48-BC90-B61EF9A69513Q37113536-CCE66E9B-2519-4375-AF1E-84511F7C5225Q37158784-17968D01-8220-4FEE-AB16-16DFFEF2DE3EQ37171783-501A35E5-CCA5-4C16-B326-F776E0819E6CQ37260128-B417A982-2740-4DB4-B27F-96A73DA28B07Q37300447-3D7D47CA-C32B-4F5E-B57E-D2CD9E19CAA8Q37462824-A8C091B3-C307-4114-9364-02B2694F05EEQ37719826-9828B4AB-F06F-4B13-8E43-5587559CB5C1Q37952822-A14B341E-66E1-43FB-B93B-6F9E30D7C87AQ38154917-9B94CDD1-DB0E-4A5C-AED7-AF17A7367D5FQ38156156-E900AD6C-B624-4A18-9E2B-A1845145934EQ38168856-E4C107B4-F446-4131-8A34-D094AAF486C5Q38366733-D8C19034-1B68-42FA-AA9F-FA92A525DE45Q38619770-C92BA84D-0FAC-412C-B6C9-77A7D5F138FFQ38694667-2BABADCB-9F5D-41F1-AE9A-50A84CDD15F8Q38738216-D1BD3C83-29FF-4DA7-A17C-CD8DB0F699EFQ38823641-6F394EB5-D561-41FA-98B0-1155B6AF6A02
P2860
Altered expression of neurotrophic factors in patients with major depression
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Altered expression of neurotrophic factors in patients with major depression
@ast
Altered expression of neurotrophic factors in patients with major depression
@en
Altered expression of neurotrophic factors in patients with major depression
@nl
type
label
Altered expression of neurotrophic factors in patients with major depression
@ast
Altered expression of neurotrophic factors in patients with major depression
@en
Altered expression of neurotrophic factors in patients with major depression
@nl
prefLabel
Altered expression of neurotrophic factors in patients with major depression
@ast
Altered expression of neurotrophic factors in patients with major depression
@en
Altered expression of neurotrophic factors in patients with major depression
@nl
P2093
P3181
P1476
Altered expression of neurotrophic factors in patients with major depression
@en
P2093
Hiromasa Funato
Koji Otsuki
Michiko Fujimoto
Shusaku Uchida
Toshio Matsubara
Toshio Watanuki
Yoshifumi Watanabe
Yusuke Wakabayashi
P304
P3181
P356
10.1016/J.JPSYCHIRES.2008.01.010
P407
P577
2008-10-01T00:00:00Z